Green molecular image.jpg

Australian Venture Catalyst for New Drug Discovery

Australia, in particular the state of Victoria, is internationally recognised for its excellence in biomedical research.  This provides a compelling opportunity for drugs discovery and biomedical science translation.

Two of Australia’s top biomedical research universities, the University of Melbourne and Monash University, have come together to establish BioCurate Pty Ltd.

BioCurate’s purpose is to propel important discoveries out of the lab to generate new therapies.  The company will specifically address the ‘valley of death’, barriers that limit the translation and commercialisation of early stage research thereby increasing the quantity and quality of discovery projects progressing to a new drug therapy and providing benefits to patients.  This is a new model for these two Universities and one of only a small number of similar initiatives globally.